Aster DM Targets Tier-2 Cities to Challenge Apollo Hospitals' Lead

Aster DM Healthcare has established its objective to become India’s largest hospital chain, implementing an aggressive expansion plan in Tier-2 cities like Indore, Raipur, Aurangabad and Bhubaneswar...

WIKA India Launches 'Re-Inventing Hygiene' for Pharma Standards

WIKA Instruments India, the world's leading precision measurement solution provider, has introduced its newest strategic movement titled 'Re-Inventing Hygiene' to revolutionize the standard of hygiene in the pharmaceutical sector.

Emcure Launches Emcure Wellness to Expand Pharma Portfolio

Emcure Pharmaceuticals has incorporated a new wholly-owned subsidiary, Emcure Wellness Private Limited, indicating a strategic direction towards diversifying within India's growing healthcare and wellness sector. The new subsidiary was formed on...

Advanced Prostate Cancer Therapy Trial Gains Backing from RedHill Biopharma

A substantial milestone in the therapeutic market of advanced prostate cancer, RedHill Biopharma Ltd. has launched the patient enrollment in a larger Phase 2 study focusing on metastatic castrate-resistant prostate cancer (mCRPC). The project indicat

Lupin Expands US Market Presence with New Complex Generic Nasal Spray

In an aim to expand in the high-value complex generics, Indian pharma major Lupin has introduced Ipratropium Bromide Nasal Solution to the United States. The product is the 0.03 percent and 0.06 percent generic equivalent of Atrovent Nasal Spray, whi

Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities

Biosimilar market in India is poised to boom in 2025, due to increasing rates of chronic diseases, patent expiration, and also a favorable policy environment. Within the domestic revenue, the biosimilars portion grew from roughly USD 866 million

Asahi Kasei Advances Research to Ease Chemotherapy Nerve Symptoms

In a Phase III research of ART-123, Asahi Kasei Pharma has begun trial drug administration in Japan to avoid symptoms associated with chemotherapy-induced peripheral neuropathy. This statement comes after positive results from previous Phase I and II

Telangana Aims to Be India's Leading Health Tourism Destination

Telangana Chief Minister A. Revanth Reddy has rolled out an ambitious proposal to make Telangana the foremost state in India as a health tourism State. In his remarks during the launch...

Cadila Pharma Launches Bilacad Dex Syrup for Allergy Relief

Cadila Pharmaceuticals has launched Bilacad Dex Syrup, a fixed-dose combination for meeting the mounting burden of respiratory and allergic conditions.

Welcure Secures Rs 85.6 Cr Export Orders, Strengthens Global Play

Welcure Drugs & Pharmaceuticals announced two significant export sourcing orders worth ?85.6 crore, signaling yet another step toward global pharmaceutical sourcing solutions. The dual sets of contracts were from Thailand-based clients...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.